FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Butch Jason
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/27/2021 

3. Issuer Name and Ticker or Trading Symbol

AGILE THERAPEUTICS INC [AGRX]
(Last)        (First)        (Middle)

101 POOR FARM ROAD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Principal Accounting Officer /
(Street)

PRINCETON, NJ 08540      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 10000 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)  (1)6/30/2030 Common Stock 50000 $2.81 D  

Explanation of Responses:
(1) This option was granted on July 1, 2020. 25% of the shares subject to the stock option vest on July 1, 2021, and the remaining shares vest in 36 equal monthly installments over the following three years such that the option will be fully vested on July 1, 2024.

Remarks:
Exhibit List - 24.1 Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Butch Jason
101 POOR FARM ROAD
PRINCETON, NJ 08540


Principal Accounting Officer

Signatures
/s/ Geoffrey P. Gilmore, Attorney-in-Fact1/28/2021
**Signature of Reporting PersonDate

Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Agile Therapeutics Charts.
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Agile Therapeutics Charts.